Aventus Thrombectomy System
Commercial- Indications
- Peripheral vascular disease, Venous thromboembolism
Company intelligence / Profile preview
Inquis Medical
Menlo Park, California, United Statesinquismedical.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Inquis Medical’s AVENTUS Thrombectomy System is a next-generation mechanical thrombectomy platform with proprietary tissue-sensing technology, enabling precise clot removal and autologous blood reinfusion. The device received FDA 510(k) clearance for both peripheral vascular and pulmonary embolism indications. Pivotal clinical trials demonstrated excellent safety and performance, with no device-related major adverse events and rapid improvement in right heart strain among PE patients. The company is preparing to commercially launch the product in 2025.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceMechanical thrombectomy systemBlood reinfusion system
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Inquis Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inquis Medical.